Back to Search
Start Over
Ethris receives UK MHRA nod to begin phase I study of ETH47, a first-in-class inhaled mRNA for respiratory viral infections
- Source :
- PharmaBiz. November 29, 2023
- Publication Year :
- 2023
-
Abstract
- Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, announced that it has received approval from the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.774672012